TORONTO, June 25, 2026 /CNW/ - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company advancing anti-inflammatory an ...
The 2026 cohort comprises eight graduate trainees, who will be placed across a range of departments within Bahrain Bourse and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results